Alterations of lymphoid enhancer factor-1 isoform expression in solid tumors and acute leukemias

Acta Biochimica et Biophysica Sinica

Volumn 37, Issue 3, 2005, Pages 173-180

  Wang, Wenbing ^a   Ji, Ping ^b   Steffen, Björn ^b   Metzger, Ralf ^b   Schneider, Paul M ^b   Halfter, Hartmut ^c   Schrader, Mark ^d   Berdel, Wolfgang E ^b   Serve, Hubert ^b   Müller Tidow, Carsten ^b  

^a Jiangsu University   (China)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

AML; Isoform; Lymphoid enhancer factor (LEF 1); Solid tumor; catenin

Indexed keywords

BETA CATENIN; ISOPROTEIN; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BRAIN CANCER; BRAIN LEVEL; CANCER DIAGNOSIS; CARCINOGENICITY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE; SENSITIVITY ANALYSIS; SOLID TUMOR; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; TISSUE LEVEL; TUMOR BIOPSY;

EID: 21144435076     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2005.00023.x     Document Type: Article

References (28)

1. 3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J Cell Biol, 2003, 163(6): 1291-1301
2. Oosterwegel MA, van de Wetering ML, Holstege FC, Prosser HM, Owen MJ, Clevers HC. TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers. Int Immunol, 1991, 3(11): 1189-1192
3. Hovanes K, Li TWH, Waterman ML. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res, 2000, 28(9): 1994-2003
4. Hovanes K, Li TWH, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF et al. β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet, 2001, 28(1): 53-57
5. Kobielak A, Kobielak K, Trzeciak WH. A novel isoform of human lymphoid enhancer-binding factor-1 (LEF-1) gene transcript encodes a protein devoid of HMG domain and nuclear localization signal. Acta Biochim Pol, 2001, 48(1): 221-226
6. Giese K, Kingsley C, Kirshner JR, Grosschedl R. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev, 1995, 9(8): 995-1008
7. Bruhn L, Munnerlyn A, Grosschedl R. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCR alpha enhancer function. Genes Dev, 1997, 11(5): 640-653
8. Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature, 1995, 376(6543): 791-795
9. Kratochwil K, Dull M, Farinas I, Galceran J, Grosschedl R. LEF1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev, 1996, 10(11): 1382-1394
10. Muller-Tidow C, Metzger R, Kugler K, Diederichs S, Idos G, Thomas M, Dockhorn-Dworniczak B et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res, 2001, 61(2): 647-653
11. Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev, 2001, 11(5): 547-553
12. Kim K, Lu Z, Hay ED. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int, 2002, 26(5): 463-476
13. Behrens J. Control of β-catenin signaling in tumor development. Ann NY Acad Sci, 2000, 910: 21-33; discussion 33-35
14. Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC et al. Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer, 2000, 28(4): 443-453
15. Lipinski KS, Djeha HA, Gawn J, Cliffe S, Maitland NJ, Palmer DH, Mountain A et al. Optimization of a synthetic β-catenin-dependent promoter for tumor-specific cancer gene therapy. Mol Ther, 2004, 10(1): 150-161
16. Henderson BR, Galea M, Schuechner S, Leung L. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of β-catenin. Regulation by histone deacetylase 1. J Biol Chem, 2002, 277(27): 24258-24264
17. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol, 1998, 8(10): 573-581
18. Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology, 2004, 36(2): 120-128
19. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem, 2002, 277(20): 17901-17905
20. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J, 1997, 16(13): 3797-3804
21. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ et al. Identification of c-MYC as a target of the APC pathway. Science, 1998, 281(5382): 1509-1512
22. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999, 398: 422-426
23. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene, 1999, 18: 2883-2891
24. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol, 1999, 155: 1033-1038
25. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med, 2001, 7(4): 444-451
26. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol, 2001, 154(2): 369-387
27. Easwaran V, Pishvaian M, Salimuddin, Byers S. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol, 1999, 9(23): 1415-1418
28. Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol, 2004, 24(7): 2890-2904